Summary
Potency determination of porcine, bovine and human insulins relative to the International Standard in the pharmacopoeial rabbit bioassay system requires that the log-dose response curves are parallel. Furthermore, the same relative potency should be obtained independent of how the hypoglycaemic response is defined. The results of 508 rabbit blood glucose assays have been analyzed by new multivariate statistical methods. No deviations from parallelism of the log-dose response curves were detected. However, the potencies showed significant variation depending on the blood sampling times. Pure porcine and human (semisynthetic and biosynthetic) insulin potencies decreased by 12% and 18%, respectively, from the 30-min to the 2.5-h response, whereas bovine insulin potencies increased by 9%. Since the standard is a 52:48 mixture of bovine and porcine insulins, these results could be due to porcine and human insulins having a quicker onset and shorter duration of hypoglycaemic effect than bovine insulin. This was confirmed in assays of bovine relative to porcine insulin and by direct comparison of mean blood glucose curves. It is concluded that there is a response time-dependent variation in potency when the test and standard insulin have a different species composition. Hence, pure species insulin standards — a porcine, a bovine and a human standard — are needed for assay of the three insulins.
Article PDF
Similar content being viewed by others
References
Chawdhury SA, Dodson EJ, Dodson GG, Reynolds CD, Tolley S, Cleasby A, Wood SP, Pitts JE (1982) The crystal structure of two-zinc human insulin. In: Gueriguian JL, Bransome ED, Out-schoorn AS (eds) Hormone drugs, proceedings of the FDA/USP Workshop on Drug and Reference Standards for Insulins, Somatropins and Thyroid-axis Hormones. United States Pharmacopeial Convention Inc, Rockville, pp 106–115
Schlichtkrull J (1956) Insulin crystals II. Shape of rhombohedral zinc-insulin crystals in relation to species and crystallization media. Acta Chem Scand 10: 1459–1464
Schlichtkrull J (1958) Insulin crystals. Chemical and biological studies on insulin crystals and insulin zinc suspensions. Dissertation, Copenhagen University
Schlichtkrull J, Pingel M, Heding LG, Brange J, Jørgensen KH (1975) Insulin preparations with prolonged effect. In: Hasselblatt A, Bruchhausen Fv (eds) Insulin II, Handbook of Experimental Pharmacology XXXII/2. Springer, Berlin Heidelberg New York, pp 729–777
Vølund Aa, Pingel M, Sørensen E (1982) Differential potency of pork and beef insulin in the USP rabbit bioassay system. In: Gueriguian JL, Bransome ED, Outschoorn AS (eds) Hormone drugs, Proceedings of the FDA/USP Workshop on Drug and Reference Standards for Insulins, Somatropins and Thyroid axis Hormones. United States Pharmacopeial Convention Inc, Rockville, pp 208–215
Vølund Aa (1980) Multivariate bioassay. Biometrics 36: 225–236
Vølund Aa (1982) Combination of multivariate bioassay results. Biometric 38: 181–190
Markussen J (1981) Human Monocomponent Insulin aus Schweine-Rohinsulin. In: Petersen KG, Schlüter KT, Kerp L (eds) Proceedings First International Symposium: Neue Insuline. Freiburger Graphische Betriebe 1982, pp 38–44
Chance RE, Kroeff EP, Hoffmann JA, Frank BH (1981) Chemical, physical and biologic properties of biosynthetic human insulin. Diabetes Care 4: 147–154
Jørgensen KH, Brange J, Hallund O, Pingel M (1970) A method for the preparation of essentially pure insulin. In: Rodrigues RR, Ebling FJG, Henderson I, Assan R (eds) International congress series No. 209. VII Congress of the International Diabetes Federation, Amsterdam, Excerpta Medica Foundation. Abstract p 149
Schlichtkrull J, Brange J, Christiansen AH, Hallund O, Heding LG, Jørgensen KH (1972) Clinical aspects of insulin — antigenicity. Diabetes 21 (Suppl 2): 649–656
Schlichtkrull J, Brange J, Christiansen AH, Hallund O, Heding LG, Jørgensen KH, Rasmussen SM, Sørensen E, Vølund Aa (1974) Monocomponent insulin and its clinical implications. Horm Metab Res (Suppl 5): 134–143
Heding LG, Larsen UD, Markussen J, Jørgensen KH, Hallund O (1974) Radioimmunoassays for human, pork and ox C-peptides and related substances. Horm Metab Res (Suppl) 5: 40–43
Heding LG (1971) Radioimmunological determination of pancreatic and gut glucagon in plasma. Diabetologia 7: 10–19
Tronier B (1979) Radioimmunological determination of pancreatic polypeptide. 14th Ann Meeting of the Scandinavian Society for the Study of Diabetes, Oulu. Acta Endocrinol 91 [Suppl] 227: 72
Tronier B, Larsen UD (1982) Somatostatin-like immunoreactivity in man. Measurement in peripheral plasma. Diabete Metab 8: 35–40
Fahrenkrug J, Muckadell OBS de (1977) Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma. J Lab Clin Med 89: 1379–1388
Markussen J, Damgaard U, Pingel M, Snel L, Sørensen AR, Sørensen E (1983) Human insulin (Novo): chemistry and characteristics. Diabetes Care 6: 4–8
Jørgensen KH, Hallund O, Heding LG, Tronier B, Falholt K, Damgaard U, Thim L, Brange J (1982) Estimation of insulin purity in light of developments in analytical methods. In: Gueriguian JL, Bransome ED, Outschoorn AS (eds) Hormone Drugs, Proceedings of the FDA/USP Workshop on Drug and Reference Standards for Insulins, Somatropins and Thyroid-axis Hormones. United States Pharmacopeial Convention Inc, Rockville. pp 139–147
United States Pharmacopeia (1980) Design and analysis of biological assays. Insulin assay, pp 891–901
Bangham DR, Mussett MV (1959) The fourth international standard for insulin. Bull WHO 20: 1209–1220
Hoffman WS (1937) A rapid photoelectric method for the determination of glucose in blood and urine. J Biol Chem 120: 51–55
Léon P, Sansur M, Snyder LR, Horváth C (1977) Continuous flow analysis for glucose, triglycerides, and ATP with immobilized enzymes in tubular form. Clin Chem 23: 1556–1562
Finney DJ (1971) A twin cross-over assay of insulin. In: Statistical method in biological assay. Griffin, London, pp 267–272
Pingel M, Vølund Aa, Sørensen E, Sørensen AR (1982) Assessment of insulin potency by chemical and biological methods. In: Gueriguian JL, Bransome ED, Outschoorn AS (eds) Hormone drugs, Proceedings of the FDA/USP Workshop on Drug and Reference Standards for Insulins, Somatropins and Thyroid-axis Hormones. United States Pharmacopeial Convention Inc, Rockville, pp 200–207
Kroeff EP, Chance RE (1982) Applications of high-performance liquid chromatography for analysis of insulins. In: Gueriguian JL, Bransome ED, Outschoorn AS (eds) Hormone drugs, Proceedings of the FDA/USP Workshop on Drug and Reference Standards for Insulins, Somatropins and Thyroid-axis Hormones. United States Pharmacopeial Convention Inc, Rockville, pp 148–162
Home PD, Alberti KGMM (1982) Human insulin. Clin Endocrinol Metab 11: 453–483
Federlin K, Laube H, Velcovsky HG (1981) Biologic and immunologic in vivo and in vitro studies with biosynthetic human insulin. Diabetes Care 4: 170–174
Keen H, Pickup JC, Bilous RW, Glynne A, Viberti GC, Jarrett RJ (1980) Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men. Lancet 2: 398–401
Owens DR, Jones MK, Hayes TM, Heding LG, Alberti KGMM, Home PD, Burrin JM, Newcombe RG (1981) Human insulin: study of safety and efficancy in man. Br Med J 282: 1264–1266
Chisholm DJ, Kraegen EW, Hewett MJ, Lazarus L (1983) Comparison of potency of porcine insulin and semisynthetic human insulin at 3 dose levels using the euglycaemic clamp. Horm Metab Res 15: 415–418
Schluter KJ, Enzmann F, Kerp L (1983) Different potencies of biosynthetic human and purified porcine insulin. Horm Metab Res 15: 271–274
Sonnenberg GE, Kenner FW, Cüppers HJ, Berger M (1983) Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy. Diabetes Care 6: 35–39
Sundermann S, Hauff C, Cüppers HJ, Broermann C, Schütte M, Berger M (1981) Absorptionskinetik und biologische Aktivität von semisynthetischem Human-Insulin (Novo). Aktuel Endocrinol Stoffw 2: 116
Bottermann P, Gyarame H, Wahl K, Ermlu R, Lebender A (1981) Pharmacokinetics of biosynthetic human insulin and characteristics of its effect. Diabetes Care 4: 168–169
Pramming S, Lauritzen T, Thorsteinsson B, Johansen K, Binder C (1984) Absorption of soluble and isophane semi-synthetic human and porcine insulin in insulin-dependent diabetic subjects. Acta Endocrinol 105: 215–220
Sestoft L, Vølund Aa, Gammeltoft S, Birch K, Hildebrandt P (1982) The biological properties of human insulin: subcutaneous absorption, receptor binding and the clinical effect in diabetics assessed by a new statistical method. Acta Med Scand 212: 21–28
Owens DR, Jones MK, Birtwell AJ, Burge CTR, Jones IR, Heyburn PJ, Hayes TM, Heding LG (1984) Pharmacokinetics of subcutaneously administered human, porcine and bovine neutral soluble insulin in normal man. Horm Metabol Res 16: 195–199
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pingel, M., Vølund, A., Sørensen, E. et al. Biological potency of porcine, bovine and human insulins in the rabbit bioassay system. Diabetologia 28, 862–869 (1985). https://doi.org/10.1007/BF00291079
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00291079